GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanxi Zhendong Pharmaceutical Co Ltd (SZSE:300158) » Definitions » ROCE %

Shanxi Zhendong Pharmaceutical Co (SZSE:300158) ROCE % : 2.39% (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shanxi Zhendong Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shanxi Zhendong Pharmaceutical Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 2.39%.


Shanxi Zhendong Pharmaceutical Co ROCE % Historical Data

The historical data trend for Shanxi Zhendong Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanxi Zhendong Pharmaceutical Co ROCE % Chart

Shanxi Zhendong Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.77 5.85 44.16 0.12 -0.69

Shanxi Zhendong Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 1.69 -1.38 -3.68 2.39

Shanxi Zhendong Pharmaceutical Co ROCE % Calculation

Shanxi Zhendong Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-36.492/( ( (6550.915 - 1209.333) + (6180.497 - 917.074) )/ 2 )
=-36.492/( (5341.582+5263.423)/ 2 )
=-36.492/5302.5025
=-0.69 %

Shanxi Zhendong Pharmaceutical Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=125.152/( ( (6180.497 - 917.074) + (5984.488 - 784.102) )/ 2 )
=125.152/( ( 5263.423 + 5200.386 )/ 2 )
=125.152/5231.9045
=2.39 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanxi Zhendong Pharmaceutical Co  (SZSE:300158) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Shanxi Zhendong Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Shanxi Zhendong Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanxi Zhendong Pharmaceutical Co (SZSE:300158) Business Description

Traded in Other Exchanges
N/A
Address
Zhendong Technology Park, Guang Road, Changzhi County, Changzhi, CHN, SXI 047100
Shanxi Zhendong Pharmaceutical Co Ltd together with its subsidiaries, researches, develops, manufactures, and markets pharmaceutical products and Chinese medicines in China. It offers anticancer drugs, cardiovascular disease prevention and control drugs and anti-infection drugs among others. The company categorizes its product as Chinese & Western Medicine, Wuhe Food, Home Care Products and Traditional Chinese Medicine.
Executives
Miao Hui Director
Ma Shi Feng Executives
Li Zhi Xu Executives
Li Xi Hai Director
You Rong Li Executives
Wang Xu Wen Executives
Dong Mi Zhu Directors, executives
Li Ren Hu Supervisors
Ning Lu Hong Directors, executives
Wang Li Qing Supervisors
Jin Zhi Xiang Supervisors

Shanxi Zhendong Pharmaceutical Co (SZSE:300158) Headlines

No Headlines